Bladder & Kidney Cancer Academy

(co-hosted with Specialty Networks)

JOIN US: September 24-26, 2026 at the Westin Denver Airport

Receive an intensive education on the most recent breakthroughs & approvals for all stages of bladder & kidney cancer. Our expert faculty will present, discuss, and debate all available preventative, diagnostic, therapeutic, and management options for bladder & kidney cancer in a highly interactive format, via didactic lectures as well as case-based and panel discussions. The meeting will begin on Thursday at noon and there will be a welcome reception Thursday and a networking reception on Friday evening.

Learn More Here

Earn CME credit at the Bladder & Kidney Cancer Academy

Designed for teams dedicated to bladder and kidney cancer care, this event delivers practical education on patient identification, care management, diagnostics, and treatment advances. This year, attendees can earn up to 2.5 AMA PRA Category 1 Credits™ through two new CME-accredited sessions focused on emerging bladder-preserving therapies in intermediate-risk non-muscle invasive bladder cancer (IR-NMIBC) and the evolving role of immuno-oncology therapies in urology practice.

FULL AGENDA

Thursday – Kidney Cancer Focus:

Thursday’s programming is dedicated entirely to kidney cancer. Experience expert-led sessions from leading academic and community urologists, in-depth case discussions, and practical updates on advanced disease and biomarkers—all capped off by an evening Welcome Reception where attendees can network with with faculty and peers.

Friday – Bladder Cancer & CME Focus:

Friday centers on bladder cancer, featuring 2.5 AMA PRA Category 1 Credits™ of accredited education. Sessions cover intermediate-risk NMIBC and the integration of immunotherapy into everyday practice, plus networking breaks followed by additional clinical programming and a closing reception with colleagues and industry partners.

REGISTRATION: Learn more here.

Read about the 2025 event below . . .

Leaders Unite at the 2025 Bladder & Kidney Cancer Academy

The 2025 Bladder & Kidney Cancer Academy, co-hosted by Specialty Networks and LUGPA, convened October 16–18 at the Hilton BNA in Nashville, drawing participants from leading independent urology practices nationwide. Under the direction of Dr. Neal Shore and Dr. Tom Jayram, the Academy delivered an intensive three-day agenda focused on clinical excellence, innovation, and collaboration in the management of kidney and bladder cancers.

The program featured expert presentations on the latest treatment approaches for localized and advanced renal cell carcinoma, non–muscle invasive bladder cancer, and upper tract urothelial carcinoma. Attendees explored advances in imaging, systemic therapies, and biomarkers, as well as surgical and radiation innovations shaping the next decade of genitourinary oncology.

Interactive case discussions, panel debates, and industry updates from leading pharmaceutical and biotech partners provided real-world context and practical takeaways. Physicians engaged in robust dialogue about optimizing patient care pathways and integrating cutting-edge research into independent practice settings.

The Academy also provided an unparalleled opportunity for networking among physicians, residents, and industry partners—strengthening relationships and fostering collaboration across the LUGPA and Specialty Networks communities. As one of the year’s most anticipated specialty meetings, the Bladder & Kidney Cancer Academy reinforced its role as an essential forum for advancing patient outcomes and empowering independent urologists to lead the future of cancer care.

To see photos from the 2025 event, follow #BKCA25 on social media.